1. Home
  2. HUN vs XENE Comparison

HUN vs XENE Comparison

Compare HUN & XENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HUN
  • XENE
  • Stock Information
  • Founded
  • HUN 1970
  • XENE 1996
  • Country
  • HUN United States
  • XENE Canada
  • Employees
  • HUN N/A
  • XENE N/A
  • Industry
  • HUN Major Chemicals
  • XENE Biotechnology: Pharmaceutical Preparations
  • Sector
  • HUN Industrials
  • XENE Health Care
  • Exchange
  • HUN Nasdaq
  • XENE Nasdaq
  • Market Cap
  • HUN 2.4B
  • XENE 2.4B
  • IPO Year
  • HUN 2005
  • XENE 2014
  • Fundamental
  • Price
  • HUN $11.46
  • XENE $32.21
  • Analyst Decision
  • HUN Hold
  • XENE Strong Buy
  • Analyst Count
  • HUN 9
  • XENE 11
  • Target Price
  • HUN $14.28
  • XENE $54.82
  • AVG Volume (30 Days)
  • HUN 4.2M
  • XENE 1.5M
  • Earning Date
  • HUN 07-31-2025
  • XENE 08-07-2025
  • Dividend Yield
  • HUN 8.42%
  • XENE N/A
  • EPS Growth
  • HUN N/A
  • XENE N/A
  • EPS
  • HUN N/A
  • XENE N/A
  • Revenue
  • HUN $5,976,000,000.00
  • XENE $7,500,000.00
  • Revenue This Year
  • HUN N/A
  • XENE N/A
  • Revenue Next Year
  • HUN $5.22
  • XENE $253.71
  • P/E Ratio
  • HUN N/A
  • XENE N/A
  • Revenue Growth
  • HUN 0.02
  • XENE N/A
  • 52 Week Low
  • HUN $10.13
  • XENE $26.74
  • 52 Week High
  • HUN $25.12
  • XENE $46.00
  • Technical
  • Relative Strength Index (RSI)
  • HUN 52.68
  • XENE 50.43
  • Support Level
  • HUN $10.45
  • XENE $31.22
  • Resistance Level
  • HUN $12.15
  • XENE $33.51
  • Average True Range (ATR)
  • HUN 0.46
  • XENE 1.24
  • MACD
  • HUN 0.17
  • XENE 0.06
  • Stochastic Oscillator
  • HUN 65.59
  • XENE 40.88

About HUN Huntsman Corporation

Huntsman Corp is a USA-based manufacturer of differentiated organic chemical products. Its product portfolio comprises Methyl diphenyl diisocyanate (MDI), Amines, Maleic anhydride, and Epoxy-based polymer formulations. The company's products are used in adhesives, aerospace, automotive, and construction products, among others. Its operating segments are Polyurethanes, Performance Products, and Advanced Materials. It derives the majority of its revenue from the Polyurethanes segment,t which includes MDI, polyols, TPU (thermoplastic polyurethane), and other polyurethane-related products. Its geographical segments are the United States & Canada, Europe, Asia-Pacific, and the Rest of the world.

About XENE Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.

Share on Social Networks: